2020 Maine Session Summary
Victory in the fight against cancer requires bold new public policies that promote cancer prevention, early detection of cancer, and expand access to quality, affordable health care.
The ACS CAN Policy Forum on Access to Health Care was held on October 12th at the Universith of Maryland Medical Center and brought together Maryland’s key decision makers and leaders in business, education, medical research, cancer care, and government to explore federal and state health care policies and its impact on the delivery of cancer care, hospital administration, and innovation in cancer treatments. This premier event featured panels with hospital CEOs, pharmaceutical and health insurance leaders, employers, state and federal health care policy experts.
To view pictures from the event, visit www.facebook.com/acscanmd
Program
Welcome remarks were given by the Honorable Catherine Pugh, Mayor City of Baltimore
Opening remarks were given by the Honorable Ben Cardin, U.S. Senator from Maryland
Host and panel moderator was Dr. Kevin Cullen, Director, University of Maryland Medical Center Greenebaum Comprehensive Cancer Center
Panelists included:
· Craig Fleischmann, Vice President of Finance, University of Maryland Medical Center
· Marie L. Grant, Vice President, Public Policy and Community Affairs, CareFirst BlueCross BlueShield
· Dr. John Marshall, Director, The Ruesch Center for the Cure of GI Cancer, Chief, Hematology and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center
· The Honorable Shirley Nathan Pulliam, Maryland State Senator
· Keysha Brooks-Coley, Senior Director of Advocacy Alliances, ACS CAN
· Amy Porter-Tacoronte, Chief Administrative Officer for Cancer Services, Johns Hopkins Kimmel Cancer Center
· The Honorable Joseline Pena-Melnyk Delegate, Maryland General Assembly and Co-Chair Maryland Insurance Coverage Protection Commission
Closing remarks were given by Jacqueline Beale, Volunteer ACS CAN State Lead Ambassador
Thank you to our generous sponsors!
Gold
Bristol-Myers Squibb
Pfizer
University of Maryland Greenebaum Comprehensive Cancer Center
Silver
Amgen
Johnson & Johnson
Bronze
CareFirst Blue Cross Blue Shield
Celgene
Genentech
Maryland Dermatologic Society
Novartis
Sanofi
Friends
Horizon Foundation
Maryland Citizens Health Initiative